Biological Analysis Core
生物分析核心
基本信息
- 批准号:10552988
- 负责人:
- 金额:$ 158.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-02 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:3 year oldAdipocytesAdipose tissueAgeAgingAmino Acid SequenceAnimal ModelArchitectureAstrocytesAtlasesAttenuatedAutomobile DrivingBiologicalBiological AssayBiological MarkersBiological ModelsBiologyBirthBrainCDKN2A geneCell AgingCellsChromatinChronic DiseaseClinicCollaborationsCre driverDataData AnalysesData SetDetectionDevelopmentDiseaseElectronic Health RecordEmerging TechnologiesEnsureEpigenetic ProcessEvolutionFVB/N MouseFundingGene ExpressionGenerationsGenesGeneticGenomeGenomicsGoalsHepatocyteHeterogeneityHumanHybridsImageInbreedingInfrastructureInstitutesIonsLaboratoriesLiverLungManagement Information SystemsManuscriptsMapsMass Spectrum AnalysisMethodologyMethodsMicrogliaMidwestern United StatesMinnesotaModelingMorbidity - disease rateMouse StrainsMusMuscleMuscle CellsNeuronsOrganPathologyPatternPharmaceutical PreparationsPhenotypePhysiologyPlayPopulationProteomicsPublishingQuality ControlReportingReproducibilityResourcesRoleSampling ErrorsScientistSensitivity and SpecificitySiteSkeletal MuscleStructure of parenchyma of lungSupercomputingTechnologyTimeTissue BanksTissue atlasTissuesTransgenic MiceUniversitiesWild Type Mouseagedanalytical toolanimal tissuebasebiomarker discoverybrain tissuecell killingcell preparationcell typecohesioncytokinedigitalexperiencefrailtyhealthspanimaging facilitiesimprovedin vivoinnovationinstrumentationmembermortalitynano-stringnew technologynovelpreservationprogenitorproteogenomicsresiliencescale upsenescencesingle-cell RNA sequencingspatiotemporaltherapeutic targettissue mappingtooltranscriptomicswound healing
项目摘要
PROJECT SUMMARY
Senescent cells (SnCs) accumulate with age and contribute to morbidity and mortality in model systems. SnCs
also play a role in normal physiology, e.g., wound healing. Currently it is unclear when and where SnCs arise in
tissues with age, how heterogenous SnCs are in vivo, and how to best identify them and their role in physiology
vs. pathology, especially in humans. The goal of the Midwest Murine-Tissue Mapping Center (MM-TMC)
Biological Analysis Core (BAC) is to leverage the utility of the mouse as a model organism to map SnCs, which
will help inform the human SnC atlases under development by SenNet. We propose to validate, optimize, and
apply state-of-the-art methodologies for bulk and single cell characterization and spatiotemporal analysis of
SnCs in healthy mouse tissues over a range of ages in two genetic backgrounds. The MM-TMC BAC will focus
on adipose, skeletal muscle, liver, brain, and lung tissues from inbred C57BL/6J and f1 hybrid (C57BL/6J:FVB/n)
mice. The data generated by the BAC will be delivered to the Data Analysis Core (DAC) for integration to develop
SnC atlases for the five tissues. The BAC will be led by Nathan LeBrasseur, an expert in the identification and
characterization of SnCs in skeletal muscle and lung in mice and humans, and in biomarker discovery; Paul
Robbins, an expert in senolytic development; and Laura Niedernhofer, an expert in the study of SnCs in
transgenic mice. The three MPIs are part of a P01 led by Overall PI Sundeep Khosla, which develops,
characterizes, and utilizes innovative transgenic mice that permit the induction of SnCs in a particular organ or
cell type, report expression of the SnC-driving genes p16Ink4a or p21Cip1, or specifically kill cells expressing those
genes. These mice will be important tools in SenNet for mapping efforts and validating probes to detect SnCs.
The BAC analytical workflow will be based within existing cores at Mayo Clinic and University of Minnesota
(UMN) to guarantee a stable infrastructure and high quality control standards: the UMN Imaging Centers, the
UMN Genomics Center, Mayo CyTOF Core, the UMN Center for Mass Spectrometry and Proteomics (CMSP),
the UMN Cytokine Reference Laboratory, and Minnesota Supercomputing Institute. These cores contain state-
of-the-art instrumentation available for mapping SnCs: Ionpath Multiplexed Ion Beam Mass Imaging, Visium
Spatial Gene Expression, and NanoString GeoMx Digital Spatial Profiling. In addition, the CMSP will use a
proteogenomic approach to identify novel SnC-specific protein sequences as biomarkers. These unique
resources, together with the MPIs’ expertise, will be valuable for building the 4D tissue atlases. Broadly, the BAC
proposes to: 1) Establish a pipeline of reproducible, validated, and quantitative assays to detect and characterize
SnCs in whole tissues and single cell preparations; 2) Use primary mouse cells as a controlled model for
validating analytical tools, studying the evolution of SnCs over time, and identifying novel SnC biomarkers; 3)
Scale-up the data generation pipeline and incorporate emerging technologies; and 4) Perform spatiotemporal
analysis of SnCs in the five tissues to enable the DAC to generate 4D SnC atlases.
项目摘要
衰老细胞(SNC)随着年龄的增长而积累,并导致模型系统中的发病率和死亡率。 SNC
还在正常生理学中发挥作用,例如伤口愈合。目前尚不清楚SNC在何时何地出现
随着年龄的增长,异源SNC在体内的方式以及如何最好地识别它们及其在生理中的作用
vs.病理学,尤其是在人类中。中西部鼠组织映射中心(MM-TMC)的目标
生物分析核心(BAC)是要利用小鼠作为模型生物的效用来映射SNC,这
将有助于告知Sennet正在开发的人类SNC地图集。我们建议验证,优化和
应用最先进的方法,用于批量和单细胞表征和空间时间分析
在两个遗传背景中,健康小鼠组织中的SNC在各种年龄范围内。 MM-TMC BAC将聚焦
关于脂肪,骨骼肌,肝脏,大脑和肺组织,来自近交C57BL/6J和F1杂种(C57BL/6J:FVB/N)
老鼠。 BAC生成的数据将被传递到数据分析核心(DAC)以进行集成以开发
五个组织的SNC地图集。 BAC将由Nathan Lebrasseur领导,该识别专家
在小鼠和人类中的骨骼肌和肺中SNC的表征,以及生物标志物的发现;保罗
罗宾斯(Robbins),鼻溶性开发专家;和SNC研究专家Laura Niedernhofer
转基因小鼠。这三个MPI是由Pi Sundeep Khosla总体领导的P01的一部分,该Pi Sundeep Khosla是发展的。
表征并利用允许在特定器官或
细胞类型,报告SNC驱动基因P16INK4A或P21CIP1的报告表达,或专门杀死表达这些的细胞
基因。这些小鼠将是Sennet中的重要工具,用于映射工作和验证问题以检测SNC。
BAC分析工作流将基于Mayo诊所和明尼苏达大学的现有核心内
(UMN)保证稳定的基础设施和高质量控制标准:UMN成像中心,
UMN基因组学中心,Mayo Cytof Core,UMN质谱和蛋白质组学中心(CMSP),
UMN细胞因子参考实验室和明尼苏达州超级计算研究所。这些核心包含状态 -
可用于映射SNC的艺术仪器:离子Pather多路复用离子束质量成像,森林
空间基因表达和纳米弦Geomx数字空间分析。此外,CMSP将使用
蛋白质生成方法将新型SNC特异性蛋白序列鉴定为生物标志物。这些独特
资源以及MPI的专业知识,对于建造4D组织地图集将是有价值的。从广义上讲,bac
提案:1)建立可再现,经过验证和定量测定的管道,以检测和表征
整个组织和单细胞制剂中的SNC; 2)使用原代小鼠细胞作为受控模型
验证分析工具,研究SNC随着时间的流逝的演变以及识别新型SNC生物标志物; 3)
扩展数据生成管道并结合新兴技术; 4)执行时空
分析五个组织中的SNC,使DAC能够生成4D SNC地图集。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nathan K LeBrasseur其他文献
Nathan K LeBrasseur的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nathan K LeBrasseur', 18)}}的其他基金
Senescence and Growth Differentiation Factors as Modifiers of Aging
衰老和生长分化因子作为衰老调节剂
- 批准号:
9755279 - 财政年份:2018
- 资助金额:
$ 158.7万 - 项目类别:
Senescence and Growth Differentiation Factors as Modifiers of Aging
衰老和生长分化因子作为衰老调节剂
- 批准号:
10378047 - 财政年份:2018
- 资助金额:
$ 158.7万 - 项目类别:
Interdisciplinary Infrastructure for Aging Research: Rochester Epidemiology Project
老龄化研究的跨学科基础设施:罗切斯特流行病学项目
- 批准号:
10208373 - 财政年份:2018
- 资助金额:
$ 158.7万 - 项目类别:
Interdisciplinary Infrastructure for Aging Research: Rochester Epidemiology Project
老龄化研究的跨学科基础设施:罗切斯特流行病学项目
- 批准号:
10409783 - 财政年份:2018
- 资助金额:
$ 158.7万 - 项目类别:
Senescence and Growth Differentiation Factors as Modifiers of Aging
衰老和生长分化因子作为衰老调节剂
- 批准号:
9894701 - 财政年份:2018
- 资助金额:
$ 158.7万 - 项目类别:
Interdisciplinary Infrastructure for Aging Research: Rochester Epidemiology Project
老龄化研究的跨学科基础设施:罗切斯特流行病学项目
- 批准号:
10224079 - 财政年份:2018
- 资助金额:
$ 158.7万 - 项目类别:
Senescence and Growth Differentiation Factors as Modifiers of Aging
衰老和生长分化因子作为衰老调节剂
- 批准号:
10116228 - 财政年份:2018
- 资助金额:
$ 158.7万 - 项目类别:
相似国自然基金
CXCL1/CXCR2信号轴上调Bcl-2促进筋膜定植巨噬细胞迁移在皮下脂肪组织原位再生中的机制研究
- 批准号:82360615
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
脂肪干细胞外泌体miRNA-299a-3p调控巨噬细胞Thbs1缓解脂肪组织衰老的机制研究
- 批准号:82301753
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Arid5b调控Treg细胞脂肪组织适应性发育和代谢调控功能及机制探究
- 批准号:82371752
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
巨噬细胞Lp-PLA2对脂肪组织重塑的调控及其作用机制
- 批准号:32300977
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
巨噬细胞介导脂肪组织重构在塑化剂干扰系统能量代谢中的作用研究
- 批准号:82373625
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
A Transdisciplinary Approach to Investigating Metabolic Dysregulation in Obese Parent and Child Dyads and Risk of Colorectal Cancer
采用跨学科方法研究肥胖父母和儿童二人组的代谢失调和结直肠癌风险
- 批准号:
10684760 - 财政年份:2022
- 资助金额:
$ 158.7万 - 项目类别:
A Transdisciplinary Approach to Investigating Metabolic Dysregulation in Obese Parent and Child Dyads and Risk of Colorectal Cancer
采用跨学科方法研究肥胖父母和儿童二人组的代谢失调和结直肠癌风险
- 批准号:
10505332 - 财政年份:2022
- 资助金额:
$ 158.7万 - 项目类别:
Maternal and Infant Added Sugars Intake in Relation to Infant Adipose Tissue Accrual
母婴添加糖摄入量与婴儿脂肪组织增长的关系
- 批准号:
10518239 - 财政年份:2018
- 资助金额:
$ 158.7万 - 项目类别:
Growth and adiposity in newborns: the influence of prenatal DHA supplementation
新生儿生长和肥胖:产前补充 DHA 的影响
- 批准号:
10194481 - 财政年份:2018
- 资助金额:
$ 158.7万 - 项目类别: